Tam Abbas Ali, Özdemir Didem, Çuhacı Neslihan, Başer Hüsniye, Aydın Cevdet, Yazgan Aylin Kılıç, Ersoy Reyhan, Çakır Bekir
Department of Endocrinology and Metabolism, Faculty of Medicine, Yıldırım Beyazıt University, Ataturk Education and Research Hospital, Bilkent, 06800, Ankara, Turkey.
Department of Pathology, Ataturk Education and Research Hospital, Ankara, Turkey.
Endocrine. 2016 Sep;53(3):774-83. doi: 10.1007/s12020-016-0955-0. Epub 2016 Apr 18.
Tumor multifocality is not an unusual finding in papillary thyroid carcinoma (PTC), but its clinical significance is controversial. In this study, we aimed to evaluate impact of multifocality, tumor number, and total tumor diameter on clinicopathological features of PTC. Medical records of 912 patients who underwent thyroidectomy and diagnosed with PTC were reviewed retrospectively. Patients were grouped into four according to number of tumoral foci: N1 (1 focus), N2 (2 foci), N3 (3 foci), and N4 (≥4 foci). The diameter of the largest tumor was considered the primary tumor diameter (PTD), and total tumor diameter (TTD) was calculated as the sum of the maximal diameter of each lesion in multicentric tumors. Patients were further classified into subgroups according to PTD and TTD. Multifocal PTC was found in 308 (33.8 %) patients. Capsular invasion, extrathyroidal extension, and lymph node metastasis were significantly higher in patients with multifocal tumors compared to patients with unifocal PTC. As the number of tumor increased, extrathyroidal extension and lymph node metastasis also increased (p = 0.034 and p = 0.004, respectively). The risk of lymph node metastasis was 2.287 (OR = 2.287, p = 0.036) times higher in N3 and 3.449 (OR = 3.449, p = 0.001) times higher in N4 compared to N1. Capsular invasion, extrathyroidal extension, and lymph node metastasis were significantly higher in multifocal patients with PTD ≤10 mm and TTD >10 mm than unifocal patients with tumor diameter ≤10 mm (p < 0.001, p < 0.001 and p = 0.001, respectively). There was no significant difference in terms of these parameters in multifocal patients with PTD ≤10 mm and TTD >10 mm and unifocal patients with tumor diameter >10 mm. In this study, increased tumor number was associated with higher rates of capsular invasion, extrathyroidal extension, and lymph node metastasis. In a patient with multifocal papillary microcarcinoma, TTD >10 mm confers a similar risk of aggressive histopathological behavior with unifocal PTC greater than 10 mm.
肿瘤多灶性在甲状腺乳头状癌(PTC)中并非罕见发现,但其临床意义存在争议。在本研究中,我们旨在评估多灶性、肿瘤数量和肿瘤总直径对PTC临床病理特征的影响。回顾性分析了912例行甲状腺切除术并诊断为PTC患者的病历。根据肿瘤灶数量将患者分为四组:N1(1个病灶)、N2(2个病灶)、N3(3个病灶)和N4(≥4个病灶)。将最大肿瘤的直径视为原发肿瘤直径(PTD),总肿瘤直径(TTD)计算为多中心肿瘤中每个病灶最大直径之和。根据PTD和TTD将患者进一步分为亚组。308例(33.8%)患者发现多灶性PTC。与单灶性PTC患者相比,多灶性肿瘤患者的包膜侵犯、甲状腺外侵犯和淋巴结转移明显更高。随着肿瘤数量增加,甲状腺外侵犯和淋巴结转移也增加(分别为p = 0.034和p = 0.004)。与N1相比,N3患者淋巴结转移风险高2.287倍(OR = 2.287,p = 0.036),N4患者高3.449倍(OR = 3.449,p = 0.001)。PTD≤10 mm且TTD>10 mm的多灶性患者的包膜侵犯、甲状腺外侵犯和淋巴结转移明显高于肿瘤直径≤10 mm的单灶性患者(分别为p < 0.001、p < 0.001和p = 0.001)。PTD≤10 mm且TTD>10 mm的多灶性患者与肿瘤直径>10 mm的单灶性患者在这些参数方面无显著差异。在本研究中,肿瘤数量增加与包膜侵犯、甲状腺外侵犯和淋巴结转移率较高相关。在多灶性微小乳头状癌患者中,TTD>10 mm与肿瘤直径大于10 mm的单灶性PTC具有相似的侵袭性组织病理学行为风险。